: Designing and synthesis of recombinant fusion protein antigen Pres2 / S-C18-27 of hepatitis B and evaluating the immune responses to it using CPG7909 as adjuvant in mice, compared to Engerix B vaccine

Khosravi, Afra; gholami parizad, elaheh

Volume 1404, Issue 1 (4-2025) 2025, 1404(1): 0-0 | Back to browse issues page

Ethics code: IR.MEDILAM.REC.1395.105

Mendeley

Zotero

RefWorks

Khosravi A, gholami parizad E. : Designing and synthesis of recombinant fusion protein antigen Pres2 / S-C18-27 of hepatitis B and evaluating the immune responses to it using CPG7909 as adjuvant in mice, compared to Engerix B vaccine. Journal title 2025; 1404 (1)
URL: http://newresearch.medilam.ac.ir/article-1-3190-en.html

: Designing and synthesis of recombinant fusion protein antigen Pres2 / S-C18-27 of hepatitis B and evaluating the immune responses to it using CPG7909 as adjuvant in mice, compared to Engerix B vaccine

Afra Khosravi